Seed · Biotech · Cambridge, United Kingdom · Founded 2022 · 1–10 employees
OutSee Limited is a Cambridge-based techbio startup pioneering a genomics-first computational approach to drug target discovery. Using its proprietary AI-powered engine, Nomaly, the company predicts disease and phenotype directly from a single genome to uncover the biological drivers of disease. The platform helps identify therapeutic targets and stratify patients for precision medicine, with an initial focus on central nervous system, rare, and metabolic diseases. The company demonstrated clinical and technological promise by securing a Discovery Award from the Longitude Prize on ALS in May 2026. OutSee is also backed by prominent venture firms and has secured strategic co-discovery support from o2h discovery.
No open roles listed right now.